• "God for us!": Catholic festivals and rites in times of epidemics, Salvador-BA, Brasil, 1918-1919
• 2-Aryl-1-hydroxyimidazoles possessing antiviral activity against a wide range of orthopoxviruses, including the variola virus
• A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine beta-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus
• A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: lessons learned and evolving practices
• A Multi-pronged Approach to Addressing Global Poxviruses Vaccine Inequity: A Case of Monkeypox
• A smallpox vaccination certificate
• Age-related antibody response to Orthopoxviruses and implications for public health measures: Insights from a South Korean study
• Amsacta moorei entomopoxvirus encodes a protein kinase with dual activity and a broad substrate spectrum including two putative cellular substrates
• An Online Cross-Sectional Survey of the General Population Regarding Awareness About Monkeypox: A Study Protocol
• Analysis of Prevention, Detection, and Response Measures of Major Infectious Diseases by Modern Chinese Seaport Quarantine Institutions: A Case Study of Modern Tianjin Seaport Quarantine
• Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation?
• Aptamer and aptasensor technology for diagnosis of infectious diseases: A mini review
• Biological Characteristics and Pathogenesis of Monkeypox Virus: An Overview
• Biology of Variola Virus
• Buffalopox: An emerging zoonotic challenge
• Catalytic Asymmetric Construction of α,α-Diaryl Aldehydes via Oxo-Hydroarylation of Terminal Alkynes
• Computational discovery of tripeptide inhibitors targeting monkeypox virus A42R profilin-like protein
• COVID-19 vaccine effectiveness among South Asians in Canada
• Crisis management for the future: Building a platform to provide information on emerging and re-emerging infectious diseases from normal times in Japan
• Cryo-EM structure of orf virus scaffolding protein orfv075
• Current Status of Vaccine Development for Monkeypox Virus
• Decoding and Unravelling Mpox, Herpes, and Syphilis Infections: A State of Art Review
• Design and computational evaluation of a novel multi-epitope hybrid vaccine against monkeypox virus: Potential targets and immunogenicity assessment for pandemic preparedness
• Designing a smallpox B-cell and T-cell multi-epitope subunit vaccine using a comprehensive immunoinformatics approach
• Differential diagnosis of exanthematous viruses during the 2022 Mpox outbreak in Minas Gerais, Brazil
• Discordant performance of mpox serological assays
• Discovering vaccines: the trial tale
• Effectiveness of historical smallpox vaccination against mpox clade II in men in Denmark, France, the Netherlands and Spain, 2022
• Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision
• Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
• Essential and multifunctional mpox virus E5 helicase-primase in double and single hexamer
• Estimating the relative importance of epidemiological and behavioural parameters for epidemic mpox transmission: a modelling study
• Ethnopharmacological uses of fauna among the people of central Punjab, Pakistan
• Evaluation of monkeypox- and vaccinia-virus neutralizing antibodies before and after smallpox vaccination: A sero-epidemiological study
• Formulation of next-generation polyvalent vaccine candidates against three important poxviruses by targeting DNA-dependent RNA polymerase using an integrated immunoinformatics and molecular modeling approach
• Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: Findings with critical reanalysis from the WHO pharmacovigilance database
• Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity
• In Commemoration of Dr. Mostafa Pourtaghva Shahrestani, a Pioneer in Infectious Disease Research
• In vitro evaluation of antiviral activity in carnivorous plant species
• In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxviruses
• Insights into the emergence and evolution of monkeypox virus: Historical perspectives, epidemiology, genetic diversity, transmission, and preventative measures
• Insights into the Transmission, Host Range, Genomics, Vaccination, and Current Epidemiology of the Monkeypox Virus
• Introduction of the smallpox vaccine in Napoleonic France, as recorded in contemporary medals
• Kaspar Hauser, the Child of Europe: Are smallpox vaccination scars the clue to a 2-century-old mystery?
• Knowledge about, attitudes toward and acceptance and predictors of intention to receive the mpox vaccine among cancer patients in China: A cross-sectional survey
• Levels of antibodies against the monkeypox virus compared by HIV status and historical smallpox vaccinations: a serological study
• Molecular Detection of HPV, EBV, HSV-1, HCMV, and <em>H. pylori</em> Pathogens: An Evaluation among Polish Children with Molar Incisor Hypomineralization (MIH)
• Molecular Virology of Orthopoxviruses with Special Reference to Monkeypox Virus
• Molluscum Contagiosum Virus: Biology and Immune Response
• Monkeypox infection and pregnancy in lower and middle-income countries: Precautions &amp; recommendations
• Monkeypox Outbreak 2022, from a Rare Disease to Global Health Emergence: Implications for Travellers
• Monkeypox: A re-emerging disease
• Mpox in people with HIV: A narrative review
• Mpox Virus and its ocular surface manifestations
• Mpox-associated supraglottitis in an immunocompetent, reportedly sexually abstinent child
• Mpox: what sexual health physicians need to know?
• Multi-center evaluation of the Research Use Only NeuMoDx monkeypox virus (MPXV) fully automated real-time PCR assay
• Natural Immunomodulatory Agents as a Complementary Therapy for Poxviruses
• Navigating the human-monkeypox virus interactome: HuPoxNET atlas reveals functional insights
• Ocular manifestations of mpox
• On Wor(l)ds and Pandemics
• Pathological skin manifestations following smallpox vaccination (ACAM2000) in US military personnel, 2009-2023: a systematic review
• Possible Bioterrorism by North Korea and South Korea's Preparedness
• Potential determinants of the decline in mpox cases in Belgium: a behavioral, epidemiological and seroprevalence study
• Poxviridae Pneumonia
• Poxvirus Vaccines: Past, Present, and Future
• Poxviruses as Agents of Biological Warfare: The Importance of Ensuring Ethical Standards for Research with Viruses
• Poxviruses in Children
• Predicting vaccine effectiveness for mpox
• Profiling of viral load, antibody and inflammatory response of people with monkeypox during hospitalization: a prospective longitudinal cohort study in China
• Public health management of pertussis in adults: Practical challenges and future strategies
• Resolution of Stubborn Monkeypox With Tecovirimat in an HIV Patient
• Role of the Laboratory in the Diagnosis of Poxvirus Infections
• Serological Evidence of Mpox Virus Infection During Peak Mpox Transmission in New York City, July to August 2022
• Severe Presentation of Mpox With Skin, Lung and Pleural Involvement in a Non-HIV Infected Kidney Transplant Recipient
• Smallpox Readiness: Modern Strategies Against an Ancient Disease
• Smallpox vaccination campaigns resulted in age-associated population cross-immunity against monkeypox virus
• Social histories of public health misinformation and infodemics: case studies of four pandemics
• Study on completion and academic thought of Dou Ke Jian(The Key of Smallpox)
• Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection
• Systemic and Dermatologic Impact of Mpox: An Overview of Guideline-Based Management for Nigerian Healthcare Workers
• The 5 C model and Mpox vaccination behavior in Germany: a cross-sectional survey
• The Feasibility of Elimination of Monkeypox Virus in Nigeria: A Systematic Review
• The nuclear localization signal of monkeypox virus protein P2 orthologue is critical for inhibition of IRF3-mediated innate immunity
• The Overview of Potential Antiviral Bioactive Compounds in Poxviruses
• The Pandemic Arc: Expanded Narratives in the History of Global Health
• The Re-Emergence of Mpox: Old Illness, Modern Challenges
• The wet nurses of the Hospital Real of Santiago de Compostela between 1803 and 1808
• The willingness of healthcare workers to be vaccinated against monkeypox and their knowledge about monkeypox: A systematic review and meta-analysis
• Third-generation smallpox vaccines induce low-level cross-protecting neutralizing antibodies against Monkeypox virus in laboratory workers
• Treatment and Vaccination for Smallpox and Monkeypox
• Trimerized S expressed by modified vaccinia virus Ankara (MVA) confers superior protection against lethal SARS-CoV-2 challenge in mice
• Two cases of smallpox from 1540 CE circum-contact (early colonial) Northern Coastal Peru
• Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections
• Vaccine Development
• Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis
• Vaccine Science Diplomacy and "The Phenomenon of Man"
• Vaccinia Virus: Mechanisms Supporting Immune Evasion and Successful Long-Term Protective Immunity
• Vaccinomics: Paving the Way for Personalized Immunization
• Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus